raloxifene hydrochloride has been researched along with cetylpyridinium chloride anhydrous in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Draper, MW; Herrmann, F; Pavo, I; Rizzoli, R; Uebelhart, B | 1 |
Akercan, F; Akin, M; Akman, L; Duygu, H; Ozerkan, F; Ulukus, M | 1 |
2 trial(s) available for raloxifene hydrochloride and cetylpyridinium chloride anhydrous
Article | Year |
---|---|
Raloxifene treatment is associated with increased serum estradiol and decreased bone remodeling in healthy middle-aged men with low sex hormone levels.
Topics: Aged; Amino Acids; Biomarkers; Bone Remodeling; Creatine; Cross-Over Studies; Double-Blind Method; Estradiol; Health; Humans; Male; Middle Aged; Placebos; Raloxifene Hydrochloride; Testosterone | 2004 |
The effects of different hormone treatment on endothelial function in healthy postmenopausal women.
Topics: Adult; Brachial Artery; Drug Combinations; Endothelium, Vascular; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Health; Humans; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Postmenopause; Raloxifene Hydrochloride; Ultrasonography; Vasodilation | 2013 |